Results 121 to 130 of about 14,599 (248)

EVIDENCE-BASED MEDICINE FOR ALLERGEN-SPECIFIC IMMUNOTHERAPY

open access: diamond, 2002
Shigeharu Fujieda   +5 more
openalex   +2 more sources

Machine Learning Model for an App‐Based Tool to Assist With the Diagnosis of Canine Atopic Dermatitis

open access: yesVeterinary Dermatology, EarlyView.
Canine atopic dermatitis (cAD) is a chronic condition requiring life‐long management. Accurate diagnosis can be challenging, with no reliable diagnostic test. This study aimed to generate a simple diagnostic model for cAD. This model is a relevant prototype for an app‐based tool to support general practitioners in the diagnosis of cAD alongside ...
Xavier Langon   +2 more
wiley   +1 more source

Identification of key genes and the pathophysiology associated with allergen-specific immunotherapy for allergic rhinitis. [PDF]

open access: yesBMC Immunol, 2023
Fan K   +10 more
europepmc   +1 more source

A Novel Topical Emollient Plus for Canine Atopic Dermatitis: A Clinical Trial Assessing Efficacy and User Acceptance

open access: yesVeterinary Dermatology, EarlyView.
Background: Canine atopic dermatitis (cAD) is a common, chronic skin condition characterised by epidermal barrier dysfunction, immune dysregulation and cutaneous dysbiosis. While “emollient plus” formulations are widely used in human atopic dermatitis, their role in cAD remains underexplored. Hypothesis/Objectives: To evaluate the clinical efficacy and
Beatriz Fernandes   +8 more
wiley   +1 more source

Future of allergen-specific immunotherapy

open access: yesAllergology International, 1998
Takeru Ishikawa
doaj   +1 more source

Algorithms in Allergy: Molecular Allergology in the Context of Animal Allergy

open access: yes
Allergy, EarlyView.
Christiane Hilger   +4 more
wiley   +1 more source

Efficacy of Der f 2/Zen 1‐LAMP1 Plasmid‐Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof‐of‐Concept Study

open access: yesVeterinary Dermatology, EarlyView.
Background: DNA‐based vaccination rapidly induces strong cellular and humoral immune responses, which may be enhanced by inclusion of lysosomal‐associated membrane protein‐1 (LAMP). Objectives: This proof‐of‐concept study evaluated the efficacy and safety of a Der f 2/Zen 1‐LAMP‐based DNA vaccine immunotherapy in client‐owned dogs with nonseasonal AD ...
Petra Bizikova   +6 more
wiley   +1 more source

T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy. [PDF]

open access: yesHeliyon, 2023
Reithofer M   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy